These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21562935)

  • 41. Percutaneous treatment of lymphatic malformations.
    Shiels WE; Kang DR; Murakami JW; Hogan MJ; Wiet GJ
    Otolaryngol Head Neck Surg; 2009 Aug; 141(2):219-24. PubMed ID: 19643255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcome of uterine artery embolization for symptomatic uterine leiomyomas.
    Lohle PN; Voogt MJ; De Vries J; Smeets AJ; Vervest HA; Lampmann LE; Boekkooi PF
    J Vasc Interv Radiol; 2008 Mar; 19(3):319-26. PubMed ID: 18295689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A population-based study of intracranial arachnoid cysts: clinical and neuroimaging outcomes following surgical cyst decompression in children.
    Helland CA; Wester K
    J Neurosurg; 2006 Nov; 105(5 Suppl):385-90. PubMed ID: 17328263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical management of large venous malformations of the lower face.
    Hontanilla B; Qiu SS; Marre D
    Br J Oral Maxillofac Surg; 2013 Dec; 51(8):752-6. PubMed ID: 23830702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient-Reported Outcomes of Bleomycin Sclerotherapy for Low-Flow Vascular Malformations and Predictors of Improvement.
    Horbach SER; van de Ven JS; Nieuwkerk PT; Spuls PI; van der Horst CMAM; Reekers JA
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1494-1504. PubMed ID: 29948003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An institution-wide algorithm for direct-stick embolization of peripheral venous malformations.
    Nassiri N; Huntress LA; Simon M; Murphy S
    J Vasc Surg Venous Lymphat Disord; 2018 May; 6(3):351-357. PubMed ID: 29396158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Foot drop after ethanol embolization of calf vascular malformation: a lesson on nerve injury.
    Tay VK; Mohan PC; Liew WK; Mahadev A; Tay KH
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1165-71. PubMed ID: 22956046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment Algorithm and Clinical Outcome of Venous Malformations of the Limbs.
    Manoli T; Micheel M; Ernemann U; Schaller HE; Stahl S
    Dermatol Surg; 2015 Oct; 41(10):1164-70. PubMed ID: 26356848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of major complication following embolo-sclerotherapy for upper and lower extremity vascular malformations.
    Lim CS; Evans N; Kaur I; Papadopoulou A; Khalifa M; Tsui J; Hamilton G; Brookes J
    Vascular; 2021 Feb; 29(1):69-77. PubMed ID: 32605532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Percutaneous sclerotherapy of congenital slow-flow vascular malformations of the orbit.
    Chiramel GK; Keshava SN; Moses V; Mammen S; David S; Sen S
    Cardiovasc Intervent Radiol; 2015 Apr; 38(2):270-9. PubMed ID: 25148921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Percutaneous treatment of peripheral vascular malformations with a mixture of polidocanol and CO(2). Initial experience].
    Górriz Gómez E; Carreira JM
    Radiologia; 2008; 50(5):424-9. PubMed ID: 19055921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ethanol sclerotherapy for venous malformation.
    Steiner F; FitzJohn T; Tan ST
    ANZ J Surg; 2016 Oct; 86(10):790-795. PubMed ID: 25182969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-term side effects and patient-reported outcomes of bleomycin sclerotherapy in vascular malformations.
    Mack JM; Richter GT; Becton D; Salem O; Hill SEM; Crary SE
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27008. PubMed ID: 29431255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Venous malformations: Clinical course and management of vascular birthmark clinic cases.
    McRae MY; Adams S; Pereira J; Parsi K; Wargon O
    Australas J Dermatol; 2013 Feb; 54(1):22-30. PubMed ID: 23082725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option.
    Shaikh R; Alomari AI; Kerr CL; Miller P; Spencer SA
    Pediatr Radiol; 2016 Jul; 46(8):1179-86. PubMed ID: 26902298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An integrated multidisciplinary team approach to the management of vascular anomalies: challenges and benefits.
    Sires JD; Williams N; Huilgol SC; Harvey I; Antoniou G; Dawson J
    Pediatr Surg Int; 2020 Oct; 36(10):1149-1156. PubMed ID: 32770386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interventional management of high-flow vascular malformations.
    Rosen RJ; Nassiri N; Drury JE
    Tech Vasc Interv Radiol; 2013 Mar; 16(1):22-38. PubMed ID: 23499129
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Congenital vascular malformations: epidemiology, classification and therapeutic basis].
    Pereira Albino J
    Rev Port Cir Cardiotorac Vasc; 2010; 17(1):61-6. PubMed ID: 20972487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Marked acute tissue swelling following percutaneous sclerosis of low-flow vascular malformations: a predictor of both prolonged recovery and therapeutic effect.
    Donnelly LF; Bisset GS; Adams DM
    Pediatr Radiol; 2000 Jun; 30(6):415-9. PubMed ID: 10876829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychological comorbidities and compliance to interventional treatment of patients with cutaneous vascular malformations.
    Kenny SA; Majeed N; Zhand N; Glikstein R; Agid R; Dos Santos MP
    Interv Neuroradiol; 2016 Aug; 22(4):489-94. PubMed ID: 27177874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.